Bronx Lebanon Hospital Cntr.
Treatment regresses left ventricular hypertrophy more in women than men
Published in Cardiovascular Business Week, August 10th, 2004
"While left ventricular (LV) structure and function differ between hypertensive women and men, it remains unclear whether sex affects regression of LV hypertrophy with antihypertensive treatment," said J.N. Bella and colleagues, Bronx Lebanon Hospital Center, New York.
This team "analyzed paired echocardiograms in 500 men and 347 women enrolled in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study at baseline and after 12 months of antihypertensive treatment with either losartan [n=177 women, 242...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Legal Issues
Wyeth, lawyers for fen-phen users propose new settlement - MacroPore Biosurgery, Inc.
SurgiWrap and CardioWrap exclusive sales, distribution rights in Japan granted - Merit Medical Systems Inc.
Medical products manufacturer reports record revenues and earnings - Novartis
Cancer, heart drugs lift Swiss pharmaceutical firm's net income - Vascular Biogenics, Ltd.
Israeli biopharmaceutical firm enters U.S. business development agreement - WorldHeart Corporation
Ventricular assist maker announces preliminary second quarter financial results - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
